tetano
Editor, Senior Moderator
3 Biotech
. 2023 Oct;13(10):323.
doi: 10.1007/s13205-023-03749-y. Epub 2023 Aug 30. Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity
Ritika Khatri[SUP] 1 [/SUP], Bharat Lohiya[SUP] 1 [/SUP], Gurleen Kaur[SUP] 1 [/SUP], Vikas Maithil[SUP] 1 [/SUP], Abhishek Goswami[SUP] 1 [/SUP], Debapriyo Sarmadhikari[SUP] 1 [/SUP], Shailendra Asthana[SUP] 1 [/SUP], Sweety Samal[SUP] 1 [/SUP]
Affiliations
The spike (S) glycoprotein of the SARS-CoV-2 virus binds to the host cell receptor and promotes the virus's entry into the target host cell. This interaction is primed by host cell proteases like furin and TMPRSS2, which act at the S1/S2 and S2´ cleavage sites, respectively. Both cleavage sites have serine or proline residues flanking either the single or polybasic region and were found to be conserved in coronaviruses. Unravelling the effects of these conserved residues on the virus entry and infectivity might facilitate the development of novel therapeutics. Here, we have investigated the role of the conserved serine and proline residues in the SARS-CoV-2 spike mediated entry, fusogenicity, and viral infectivity by using the HIV-1/spike-based pseudovirus system. A conserved serine residue mutation to alanine (S2´S-A) at the S2´ cleavage site resulted in the complete loss of spike cleavage. Exogenous treatment with trypsin or overexpression of TMPRSS2 protease could not rescue the loss of spike cleavage and biological activity. The S2´S-A mutant showed no significant responses against E-64d, TMPRSS2 or other relevant inhibitors. Taken together, serine at the S2´ site in the spike protein was indispensable for spike protein cleavage and virus infectivity. Thus, novel interventions targeting the conserved serine at the S2´ cleavage site should be explored to reduce severe disease caused by SARS-CoV-2-and novel emerging variants.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-023-03749-y.
Keywords: Cell entry and viral infectivity; Conserved serine; SARS-CoV-2; Spike cleavage site.
. 2023 Oct;13(10):323.
doi: 10.1007/s13205-023-03749-y. Epub 2023 Aug 30. Understanding the role of conserved proline and serine residues in the SARS-CoV-2 spike cleavage sites in the virus entry, fusion, and infectivity
Ritika Khatri[SUP] 1 [/SUP], Bharat Lohiya[SUP] 1 [/SUP], Gurleen Kaur[SUP] 1 [/SUP], Vikas Maithil[SUP] 1 [/SUP], Abhishek Goswami[SUP] 1 [/SUP], Debapriyo Sarmadhikari[SUP] 1 [/SUP], Shailendra Asthana[SUP] 1 [/SUP], Sweety Samal[SUP] 1 [/SUP]
Affiliations
- PMID: 37663753
- PMCID: PMC10469153 (available on 2024-10-01)
- DOI: 10.1007/s13205-023-03749-y
The spike (S) glycoprotein of the SARS-CoV-2 virus binds to the host cell receptor and promotes the virus's entry into the target host cell. This interaction is primed by host cell proteases like furin and TMPRSS2, which act at the S1/S2 and S2´ cleavage sites, respectively. Both cleavage sites have serine or proline residues flanking either the single or polybasic region and were found to be conserved in coronaviruses. Unravelling the effects of these conserved residues on the virus entry and infectivity might facilitate the development of novel therapeutics. Here, we have investigated the role of the conserved serine and proline residues in the SARS-CoV-2 spike mediated entry, fusogenicity, and viral infectivity by using the HIV-1/spike-based pseudovirus system. A conserved serine residue mutation to alanine (S2´S-A) at the S2´ cleavage site resulted in the complete loss of spike cleavage. Exogenous treatment with trypsin or overexpression of TMPRSS2 protease could not rescue the loss of spike cleavage and biological activity. The S2´S-A mutant showed no significant responses against E-64d, TMPRSS2 or other relevant inhibitors. Taken together, serine at the S2´ site in the spike protein was indispensable for spike protein cleavage and virus infectivity. Thus, novel interventions targeting the conserved serine at the S2´ cleavage site should be explored to reduce severe disease caused by SARS-CoV-2-and novel emerging variants.
Supplementary information: The online version contains supplementary material available at 10.1007/s13205-023-03749-y.
Keywords: Cell entry and viral infectivity; Conserved serine; SARS-CoV-2; Spike cleavage site.